ArticleEchocardiography (Mount Kisco, N.Y.)2026
From Snapshot to Trajectory: The RV-3 Check for Pulmonary Arterial Hypertension Follow-up.
Article in Echocardiography (Mount Kisco, N.Y.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Pulmonary arterial hypertension follow-up relies on composite clinical risk assessment, yet symptoms and functional markers may not always reflect right ventricular (RV) adaptation. We propose the RV-3 Check, a practical framework for serial RV assessment using three complementary domains: remodeling, systolic performance, and RV-pulmonary arterial coupling. Each domain is classified as improving, stable, worsening, or indeterminate, with overall RV direction assigned when at least two domains change concordantly. The framework is intended to identify clinically important discordance, particularly symptomatic improvement despite progressive RV deterioration, or persistent symptoms despite objective RV recovery. The RV-3 Check does not replace ESC/ERS risk stratification or invasive hemodynamics; rather, it serves as a structured confirmation tool that may prompt repeat imaging, cardiac magnetic resonance, or right-heart catheterization when findings are uncertain or management-changing. Prospective validation is needed before it can be used as an independent treatment algorithm.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.